Lundi 03 mai 2021
8.00 – 8.30
On site registration and welcome
8.30 – 9.00
Vasculogenesis and angiogenesis
T. Naidich, USA
9.00 – 9.30
Normal cerebral vessels walls : histology, biology, perivascular spaces
M. Catala, France
9.30 – 10.00
Normal cerebral vascular wall ageing-arteries and veins
W.E Sonntag, USA
10.00 – 10.30
Intracranial vasa vasorum. Implication in neurovascular diseases Including atherosclerosis
B. Wasserman, USA
10.30 – 11.00
Coffee break
11.00 – 11.30
Vessel Wall inflammation and consequences
P. Berlit, Germany
11.30 – 12.00
Vessel wall imaging: from normal to pathological
B. T. Naidich, USA
12.00 – 12.30
Intracranial dissections and therapeutic considerations
G. Rodesch, France
12.30 – 13.30
Lunch break
13.30 – 14.00
Genetic aspects of congenital vasculopathies including HHT
M. Vikkula, Belgium
14.00 – 14.30
Phenotypic aspects of inherited vasculopathies : vascular Ehlers Danlos syndrome
X. Jeunemaître, France
14.30 – 15.00
Phenotypic aspects of congenital vasculopathies : HHT
S. Dupuis Girod, France
15.00 – 15.30
Coffee break
15.30 – 16.00
Specificities of endovascular treatments in congenital vasculopathies
A. Berenstein, USA
16.00- 16.30
Intracranial arteries stenosis : treatments
M. Marks, USA
16.30 – 17.00
Endovascular treatments: consequences on vessel walls
H. Benamer, France
17.00 – 17.30
Embolic materials and vascular wall
P. Gobin, USA
Mardi 04 mai 2021
8.00 – 8.30
Welcome
8.30 – 9.00
Metameric origin of cerebral arteries
M. Tanaka, Japan
9.00 – 9.30
Shear stress and vascular wall
G. Finet, France
9.30 – 10.00
Aneurysmal vasculopathy : from unrupture to rupture
J. Frosen, Finland
10.00 – 10.30
Aneurysmal wall imaging
R. VandenBerg, Netherlands
10.30 – 11.00
Discussion and round table : impact in pre therapeutic aneurysm assessment
M. Soderman, Sweden
11.00 – 11.30
Coffee break
11.30 – 12.30
Role of vessel wall in unruptured to ruptured cerebral AVMs
S. Hetts, USA
12.30 – 13.00
Angiogenesis and brain AVMs
A. Berenstein, USA
12.30 – 13.00
Angiogenesis in pediatric population and recurrence of AVMs
D. Orbach, USA
13.00 – 13.30
Cerebral proliferative angiopathies
A. Valavanis, Switzerland
13.30 – 14.30
Lunch break
14.30 – 15.00
Discussion and round table: impact in pre therapeutic cerebral AVMs assessment
S. Bracard, France
15.00 – 15.30
CAMS and angiogenesis in the maxillofacial area
L. Boon, Belgium
15.30 – 16.00
Angiogenesis in Moya moya and progressive arterial stenosis
M. Komiyama, Japan
16.00 – 16.30
Anti angiogenic treatments
L. Boon, Belgium
16.30 – 17.00
Cerebral collateral circulation
G. Rodesch, France
17.00
Conclusions and End of the Seminar
